misonidazole has been researched along with 6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Astor, M; Hall, EJ | 1 |
| Eady, JJ; Haslinger, RK; Peacock, JH; Schlappack, OK; Schmidt, WF | 1 |
2 other study(ies) available for misonidazole and 6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline)
| Article | Year |
|---|---|
Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
Topics: Animals; Cell Survival; Cells, Cultured; Cricetinae; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Combinations; Misonidazole; Nitroimidazoles; Oxygen; Quinolines; Radiation-Sensitizing Agents | 1979 |
Lack of radiosensitization in Lewis lung carcinoma and a murine plasmacytoma by MTDQ and MTDQ-DA.
Topics: Animals; Female; Lung Neoplasms; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Misonidazole; Plasmacytoma; Quinolines; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1988 |